vs
Side-by-side financial comparison of P10, Inc. (PX) and Neuronetics, Inc. (STIM). Click either name above to swap in a different company.
P10, Inc. is the larger business by last-quarter revenue ($81.0M vs $41.8M, roughly 1.9× Neuronetics, Inc.). P10, Inc. runs the higher net margin — 11.7% vs -17.2%, a 28.9% gap on every dollar of revenue. On growth, Neuronetics, Inc. posted the faster year-over-year revenue change (85.7% vs -4.7%). P10, Inc. produced more free cash flow last quarter ($18.1M vs $692.0K). Over the past eight quarters, Neuronetics, Inc.'s revenue compounded faster (54.9% CAGR vs 10.7%).
P10, Inc. is a global alternative investment management firm that offers a diversified portfolio of investment solutions spanning private equity, private credit, real assets and venture capital. It primarily caters to institutional clients including pension funds, endowments, foundations, and high-net-worth individuals across North America, Europe, and Asia Pacific.
Neuronetics is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003, that develops non-invasive treatments for psychiatric disorders that have shown resistance or lack of improvement using traditional medicine. The treatments are based upon neuromodulation technology.
PX vs STIM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $81.0M | $41.8M |
| Net Profit | $9.5M | $-7.2M |
| Gross Margin | — | 52.0% |
| Operating Margin | 31.9% | -12.1% |
| Net Margin | 11.7% | -17.2% |
| Revenue YoY | -4.7% | 85.7% |
| Net Profit YoY | 79.0% | 43.2% |
| EPS (diluted) | $0.08 | $-0.10 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $81.0M | $41.8M | ||
| Q3 25 | $75.9M | $37.3M | ||
| Q2 25 | $72.7M | $38.1M | ||
| Q1 25 | $67.7M | $32.0M | ||
| Q4 24 | $85.0M | $22.5M | ||
| Q3 24 | $74.2M | $18.5M | ||
| Q2 24 | $71.1M | $16.4M | ||
| Q1 24 | $66.1M | $17.4M |
| Q4 25 | $9.5M | $-7.2M | ||
| Q3 25 | $2.1M | $-9.0M | ||
| Q2 25 | $3.4M | $-10.1M | ||
| Q1 25 | $4.5M | $-12.7M | ||
| Q4 24 | $5.3M | $-12.7M | ||
| Q3 24 | $1.4M | $-13.3M | ||
| Q2 24 | $7.0M | $-9.8M | ||
| Q1 24 | $5.0M | $-7.9M |
| Q4 25 | — | 52.0% | ||
| Q3 25 | — | 45.9% | ||
| Q2 25 | — | 46.6% | ||
| Q1 25 | — | 49.2% | ||
| Q4 24 | — | 66.2% | ||
| Q3 24 | — | 75.6% | ||
| Q2 24 | — | 74.0% | ||
| Q1 24 | — | 75.1% |
| Q4 25 | 31.9% | -12.1% | ||
| Q3 25 | 14.1% | -19.6% | ||
| Q2 25 | 24.4% | -21.1% | ||
| Q1 25 | 16.6% | -34.4% | ||
| Q4 24 | 26.9% | -51.0% | ||
| Q3 24 | 11.9% | -41.7% | ||
| Q2 24 | 23.7% | -51.7% | ||
| Q1 24 | 18.3% | -39.4% |
| Q4 25 | 11.7% | -17.2% | ||
| Q3 25 | 2.8% | -24.3% | ||
| Q2 25 | 4.7% | -26.6% | ||
| Q1 25 | 6.7% | -39.6% | ||
| Q4 24 | 6.2% | -56.4% | ||
| Q3 24 | 1.9% | -72.0% | ||
| Q2 24 | 9.8% | -59.8% | ||
| Q1 24 | 7.6% | -45.2% |
| Q4 25 | $0.08 | $-0.10 | ||
| Q3 25 | $0.02 | $-0.13 | ||
| Q2 25 | $0.03 | $-0.15 | ||
| Q1 25 | $0.04 | $-0.21 | ||
| Q4 24 | $0.05 | $-0.34 | ||
| Q3 24 | $0.01 | $-0.44 | ||
| Q2 24 | $0.06 | $-0.33 | ||
| Q1 24 | $0.04 | $-0.27 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $28.2M | $28.1M |
| Total DebtLower is stronger | $373.2M | $65.8M |
| Stockholders' EquityBook value | $403.5M | $22.4M |
| Total Assets | $928.3M | $141.6M |
| Debt / EquityLower = less leverage | 0.93× | 2.94× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $28.2M | $28.1M | ||
| Q3 25 | $40.0M | $28.0M | ||
| Q2 25 | $33.4M | $11.0M | ||
| Q1 25 | $74.4M | $20.2M | ||
| Q4 24 | $67.5M | $18.5M | ||
| Q3 24 | $61.5M | $20.9M | ||
| Q2 24 | $31.2M | $42.6M | ||
| Q1 24 | $29.0M | $47.7M |
| Q4 25 | $373.2M | $65.8M | ||
| Q3 25 | $393.4M | $65.7M | ||
| Q2 25 | $373.0M | $55.5M | ||
| Q1 25 | $357.2M | $55.3M | ||
| Q4 24 | $319.8M | $55.2M | ||
| Q3 24 | $319.4M | $46.0M | ||
| Q2 24 | $300.6M | $59.8M | ||
| Q1 24 | $314.0M | $59.4M |
| Q4 25 | $403.5M | $22.4M | ||
| Q3 25 | $396.8M | $27.4M | ||
| Q2 25 | $388.9M | $27.1M | ||
| Q1 25 | $374.3M | $35.5M | ||
| Q4 24 | $386.9M | $27.7M | ||
| Q3 24 | $394.1M | $9.4M | ||
| Q2 24 | $396.9M | $19.4M | ||
| Q1 24 | $400.1M | $27.7M |
| Q4 25 | $928.3M | $141.6M | ||
| Q3 25 | $936.0M | $145.5M | ||
| Q2 25 | $932.2M | $134.7M | ||
| Q1 25 | $877.4M | $142.0M | ||
| Q4 24 | $869.3M | $140.9M | ||
| Q3 24 | $857.0M | — | ||
| Q2 24 | $823.2M | $96.8M | ||
| Q1 24 | $832.8M | $103.8M |
| Q4 25 | 0.93× | 2.94× | ||
| Q3 25 | 0.99× | 2.40× | ||
| Q2 25 | 0.96× | 2.05× | ||
| Q1 25 | 0.95× | 1.56× | ||
| Q4 24 | 0.83× | 1.99× | ||
| Q3 24 | 0.81× | 4.90× | ||
| Q2 24 | 0.76× | 3.08× | ||
| Q1 24 | 0.78× | 2.15× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $23.0M | $908.0K |
| Free Cash FlowOCF − Capex | $18.1M | $692.0K |
| FCF MarginFCF / Revenue | 22.3% | 1.7% |
| Capex IntensityCapex / Revenue | 6.0% | 0.5% |
| Cash ConversionOCF / Net Profit | 2.43× | — |
| TTM Free Cash FlowTrailing 4 quarters | $14.1M | $-21.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $23.0M | $908.0K | ||
| Q3 25 | $-8.6M | $-785.0K | ||
| Q2 25 | $13.4M | $-3.5M | ||
| Q1 25 | $-4.7M | $-17.0M | ||
| Q4 24 | $101.0M | $-8.6M | ||
| Q3 24 | $27.5M | $-5.4M | ||
| Q2 24 | $34.8M | $-5.0M | ||
| Q1 24 | $11.0M | $-12.0M |
| Q4 25 | $18.1M | $692.0K | ||
| Q3 25 | $-9.5M | $-899.0K | ||
| Q2 25 | $11.6M | $-3.8M | ||
| Q1 25 | $-6.0M | $-17.2M | ||
| Q4 24 | $96.6M | $-8.7M | ||
| Q3 24 | $25.2M | $-5.8M | ||
| Q2 24 | $33.9M | $-5.6M | ||
| Q1 24 | $10.7M | $-12.4M |
| Q4 25 | 22.3% | 1.7% | ||
| Q3 25 | -12.6% | -2.4% | ||
| Q2 25 | 15.9% | -9.9% | ||
| Q1 25 | -8.9% | -53.8% | ||
| Q4 24 | 113.6% | -38.6% | ||
| Q3 24 | 34.0% | -31.3% | ||
| Q2 24 | 47.7% | -34.0% | ||
| Q1 24 | 16.2% | -71.1% |
| Q4 25 | 6.0% | 0.5% | ||
| Q3 25 | 1.2% | 0.3% | ||
| Q2 25 | 2.5% | 0.7% | ||
| Q1 25 | 1.9% | 0.7% | ||
| Q4 24 | 5.2% | 0.4% | ||
| Q3 24 | 3.0% | 2.1% | ||
| Q2 24 | 1.3% | 3.7% | ||
| Q1 24 | 0.4% | 2.2% |
| Q4 25 | 2.43× | — | ||
| Q3 25 | -4.01× | — | ||
| Q2 25 | 3.96× | — | ||
| Q1 25 | -1.05× | — | ||
| Q4 24 | 19.12× | — | ||
| Q3 24 | 19.54× | — | ||
| Q2 24 | 4.98× | — | ||
| Q1 24 | 2.18× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PX
| Management Fees | $78.1M | 96% |
| Advisory Fees | $1.8M | 2% |
STIM
Segment breakdown not available.
